Celgene, Pharmacyclics, Ariad Pharmaceuticals, ImmunoGen, Array BioPharma Get Boost From Medical Conference
MINYANVILLE ORIGINAL Stocks for several drug makers are rising Tuesday following study results showing their therapies may be effective in treating different forms of blood diseases. The stocks some of which have been rising rapidly all year are getting a boost after scientific presentations at a big medical meeting of the American Society of Hematology in Atlanta. Celgene (NASDAQ:CELG) reported strong data showing its drug candidate pomalidomide slowed the progression of cancer and improved survival times for patients with multiple myeloma according to results presented Tuesday. The data supports a possible approval from the Food and Drug Administration in ...
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here